Pembrolizumab-associated thrombotic microangiopathy in a patient with urothelial cancer: a case report and literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab-associated thrombotic microangiopathy in a patient with urothelial cancer: a case report and literature review

Published:2020-07-06 Issue:1 Volume:6 Page:
ISSN:2059-1381
Container-title:Renal Replacement Therapy
language:en
Short-container-title:Ren Replace Ther

Author:

Hayata Manabu,Shimanuki Masaya,Ko Takehiro,Date Ryosuke,Hamaguchi Ami,Tominaga Aki,Miura Rei,Mizumoto Teruhiko,Mukoyama Masashi

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s41100-020-00278-9.pdf

Reference16 articles.

1. Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med. 2017;376(11):1015–26.

2. Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158–68.

3. Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, Le DT, Lipson EJ, Glezerman IG, Wolchok J, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016;90(3):638–47.

4. Hanna RM, Selamet U, Bui P, Sun SF, Shenouda O, Nobakht N, Barsoum M, Arman F, Rastogi A. Acute kidney injury after pembrolizumab-induced adrenalitis and adrenal insufficiency. Case Rep Nephrol Dial. 2018;8(2):171–7.

5. Jhaveri KD, Perazella MA. Adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(12):1163.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-Mediated Diabetes Mellitus, Diabetic Ketoacidosis, Enteritis, and Thrombotic Thrombocytopenic Purpura Presenting as Adverse Effects of Pembrolizumab Therapy;American Journal of Therapeutics;2024-07

2. Renal-Limited Thrombotic Microangiopathy in a Patient Who Received Gemcitabine, Ramucirumab, and Pembrolizumab: A Case Report and Literature Review;Cureus;2024-02-05

3. Nephrotoxicity in the Age of Immune Checkpoint Inhibitors: Mechanisms, Diagnosis, and Management;International Journal of Molecular Sciences;2023-12-28

4. A brief review of renal-limited thrombotic microangiopathy associated with immune checkpoint inhibitors;Journal of Onco-Nephrology;2023-01-04

5. Therapeutic plasma exchange in the management of immune checkpoint inhibitor‐associated immune‐related adverse effects: A review;Transfusion;2022-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3